Investors

Press Releases

Press Releases

Date	Title	Format
March 2, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
March 1, 2021	Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases	PDF Version
February 23, 2021	Chinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit	PDF Version
February 17, 2021	Chinook Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference	PDF Version
February 2, 2021	Chinook Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for CHK-336 for Treatment of Primary Hyperoxaluria	PDF Version
January 4, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version

IR Contact

Noopur Liffick

Vice President
Investor Relations & Corporate Communications
investors@chinooktx.com
510.809.2465

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert
Report Alert

Click here to unsubscribe from email alerts

© 2021 Chinook Therapeutics, Inc.. All rights reserved

Website Design: Hane Chow, Inc.